The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 1979, 123: 269-271.
Copyright © 1979 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dorf, M. E.
Right arrow Articles by Benacerraf, B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dorf, M. E.
Right arrow Articles by Benacerraf, B.

Gene Dose Effects in Ir Gene-Controlled Systems

Martin E. Dorf, Jack H. Stimpfling and Baruj Benacerraf

From the Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115 and the McLaughlin Research Institute, Great Falls, Montana 59401

Abstract

(B10.A x B10.S)F1 hybrid mice produce lower levels of anti-GL{varphi} antibody than B10.S(9R) and B10.HTT mice. To determine whether this difference is due to a gene dose or a cis-trans effect, [B10.S(9R) x B10.S(8R)]F1 mice were immunized with GL{varphi}. These mice carry one dose of the responder Ir gene alleles in the cis position whereas the recombinant B10.S(9R) and B10.HTT mice carry two doses of the relevant genes. Both (B10.A x B10.S) and [B10.S(9R) x B10.S(8R)] F1 mice produced comparably lower amounts of antibodies as compared to the recombinant strains. The data therefore demonstrate that gene dose and not cis-trans effect accounts for the differences between F1 and recombinant strains in their antibody response to GL{varphi} controlled by complementary Ir genes.




This article has been cited by other articles:


Home page
GeneticsHome page
P. Ilmonen, D. J. Penn, K. Damjanovich, L. Morrison, L. Ghotbi, and W. K. Potts
Major Histocompatibility Complex Heterozygosity Reduces Fitness in Experimentally Infected Mice
Genetics, August 1, 2007; 176(4): 2501 - 2508.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
C. Wedekind, M. Walker, and T. J. Little
The Course of Malaria in Mice: Major Histocompatibility Complex (MHC) Effects, but No General MHC Heterozygote Advantage in Single-Strain Infections
Genetics, July 1, 2005; 170(3): 1427 - 1430.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1979 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1979 by The American Association of Immunologists, Inc. All rights reserved.